Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾
main product photo

Cytisine - 98%, high purity , CAS No.485-35-8

1 Citations
Item Number
C107705
Grouped product items
SKUSizeAvailabilityPrice Qty
C107705-25mg
25mg
In stock
$48.90
C107705-100mg
100mg
In stock
$176.90
C107705-500mg
500mg
In stock
$793.90
C107705-1g
1g
In stock
$1,428.90
Add to Wish List Compare
Bulk Order  SDS  DATASHEET

Potent, selective nAChR agonist

View related series
Cell signal transduction and Neuroscience Membrane Transporter/Ion Channel nAChR Neuronal Signaling Pyridines

Basic Description

Synonyms(1R,9S)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one | HB2033 | s2287 | Cytisine ((+)-) | HMS2096N10 | HMS3414N03 | MLS002153916 | 1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)- | C5E | DB09028 | HMS3884L11 | N
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsPotent, selective agonist at neuronal nicotinic receptors. Acts as a partial agonist at β 2 -containing nicotinic receptors. (K i values are 2 (α4β2), 5890 (α7), 480 (α3β4), 329 (α6/α4β4) and 492 nM (α1β1γδ)).
Shipped InNormal
GradeMoligand™
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Toxic, refer to SDS for further information. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Properties

ALogP0.2

Associated Targets(Human)

CHRNA7 Tchem Neuronal acetylcholine receptor subunit alpha-7 (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA7 Tchem Neuronal acetylcholine receptor protein alpha-7 subunit (3524 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA1 Tclin Acetylcholine receptor protein alpha chain (98 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRND Tclin Acetylcholine receptor protein delta chain (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M14 (47487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-4 (44535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-5 (45555 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXF 393 (41971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SN12C (47755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-19 (46794 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TK-10 (45540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI/ADR-RES (33767 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H322M (45589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC 2998 (41480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapt Microtubule-associated protein tau (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Impa1 Inositol monophosphatase 1 (16203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna3 Neuronal acetylcholine receptor; alpha3/beta2 (421 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna2 Neuronal acetylcholine receptor; alpha2/beta4 (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna2 Neuronal acetylcholine receptor; alpha2/beta2 (198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna3 Neuronal acetylcholine receptor; alpha3/beta4 (1368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna3 Neuronal acetylcholine receptor (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA1 Acetylcholine receptor (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
nAChRalpha5 Nicotinic acetylcholine receptor alpha 5 subunit (134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name (1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one
INCHI InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1
InChi Key ANJTVLIZGCUXLD-DTWKUNHWSA-N
Canonical SMILES C1C2CNCC1C3=CC=CC(=O)N3C2
Isomeric SMILES C1[C@H]2CNC[C@@H]1C3=CC=CC(=O)N3C2
WGK Germany 3
RTECS HA4025000
PubChem CID 10235
UN Number 2811
Molecular Weight 190.24

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
K1820032Certificate of AnalysisSep 19, 2022 C107705
K1820031Certificate of AnalysisSep 19, 2022 C107705
B2225301Certificate of AnalysisDec 27, 2021 C107705
B2225316Certificate of AnalysisDec 27, 2021 C107705
B2225387Certificate of AnalysisDec 27, 2021 C107705

Chemical and Physical Properties

SolubilitySoluble in water; Soluble in Methanol,Ethanol; Slightly soluble in Benzene,Acetone
Specific Rotation[α]-112° (C=1,EtOH)
Boil Point(°C)218°C
Melt Point(°C)155°C

Safety and Hazards(GHS)

Pictogram(s) GHS06,   GHS07
Signal Danger
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H301:Toxic if swallowed

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P316:IF SWALLOWED: Get emergency medical help immediately.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 3
RTECS HA4025000
Merck Index 2789

Related Documents

 SDS

 Specification Sheet

Citations of This Product

How to Cite Aladdin Scientific Products?
1. Zhang Chunhua, Wu Huiqin, Huang Xiaolan, Zhu Zhixin, Luo Huitai, Huang Fang, Lin Xiaoshan.  (2012)  Simultaneous Determination of Toxic Alkaloids in Blood and Urine by HPLC–ESI–MS/MS.  CHROMATOGRAPHIA,  75  (9): (499-511).  [PMID:] [10.1007/s10337-012-2216-6]

References

1. Luo R et al..  (2013)  Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones..  J Physiol,  591  (Pt 1): (203-17).  [PMID:23045343]
2. Caterina Canu Boido,Bruno Tasso,Vito Boido,Fabio Sparatore.  (2003-03-07)  Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities..  Farmaco (Societa chimica italiana : 1989),  58  ((3)): (265-277).  [PMID:12620422]
3. Y E Slater,L M Houlihan,P D Maskell,R Exley,I Bermúdez,R J Lukas,A C Valdivia,B K Cassels.  (2003-03-21)  Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes..  Neuropharmacology,  44  ((4)): (503-515).  [PMID:12646287]
4. Henrik Viberg,Per Eriksson.  (2011-08-09)  Differences in neonatal neurotoxicity of brominated flame retardants, PBDE 99 and TBBPA, in mice..  Toxicology,  289  ((1)): (59-65).  [PMID:21820030]
5. Anders Ettrup,Jens D Mikkelsen,Szabolcs Lehel,Jacob Madsen,Elsebet Ø Nielsen,Mikael Palner,Daniel B Timmermann,Dan Peters,Gitte M Knudsen.  (2011-08-11)  11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements..  Journal of nuclear medicine : official publication, Society of Nuclear Medicine,  52  ((9)): (1449-1456).  [PMID:21828113]
6. Natalie Walker,Colin Howe,Chris Bullen,Hayden McRobbie,Marewa Glover,Varsha Parag,Jonathan Williman,Reon Veale,Vili Nosa,Joanne Barnes.  (2011-11-23)  Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking..  BMC public health,  11  (880-880).  [PMID:22104038]
7. Hiroto Kuwabara,Dean F Wong,Yongjun Gao,Heather Valentine,Daniel P Holt,Hayden T Ravert,Robert F Dannals,Andrew G Horti.  (2011-12-17)  PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics..  Journal of nuclear medicine : official publication, Society of Nuclear Medicine,  53  ((1)): (121-129).  [PMID:22173841]
8. Edwin G Pérez,Carolina Méndez-Gálvez,Bruce K Cassels.  (2012-03-01)  Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors..  Natural product reports,  29  ((5)): (555-567).  [PMID:22367109]
9. Colin S Cunningham,Martin A Javors,Lance R McMahon.  (2012-03-23)  Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys..  The Journal of pharmacology and experimental therapeutics,  341  ((3)): (840-849).  [PMID:22438471]
10. Kate Cahill,Lindsay F Stead,Tim Lancaster.  (2012-04-20)  Nicotine receptor partial agonists for smoking cessation..  The Cochrane database of systematic reviews,  4  ((4)): (CD006103-CD006103).  [PMID:22513936]
11. Prakash Rucktooa,Claire A Haseler,René van Elk,August B Smit,Timothy Gallagher,Titia K Sixma.  (2012-05-04)  Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein..  The Journal of biological chemistry,  287  ((28)): (23283-23293).  [PMID:22553201]
12. Clare Stokes,Roger L Papke.  (2012-05-15)  Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties..  Neuropharmacology,  63  ((4)): (538-546).  [PMID:22580377]
13. Mariaelvina Sala,Daniela Braida,Luca Pucci,Irene Manfredi,Michael J Marks,Charles R Wageman,Sharon R Grady,Barbara Loi,Sergio Fucile,Francesca Fasoli,Michele Zoli,Bruno Tasso,Fabio Sparatore,Francesco Clementi,Cecilia Gotti.  (2012-09-11)  CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation..  British journal of pharmacology,  168  ((4)): (835-849).  [PMID:22957729]
14. Yu-Jiao Li,Qi Yang,Kun Zhang,Yan-Yan Guo,Xu-Bo Li,Le Yang,Ming-Gao Zhao,Yu-Mei Wu.  (2012-10-02)  Cytisine confers neuronal protection against excitotoxic injury by down-regulating GluN2B-containing NMDA receptors..  Neurotoxicology,  34  (219-225).  [PMID:23022271]
15. Ramón Sotomayor-Zárate,Katia Gysling,Usoa E Busto,Bruce K Cassels,Lutske Tampier,María Elena Quintanilla.  (2013-01-25)  Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats..  Psychopharmacology,  227  ((2)): (287-298).  [PMID:23344555]
16. Peter Hajek,Hayden McRobbie,Katie Myers.  (2013-02-14)  Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis..  Thorax,  68  ((11)): (1037-1042).  [PMID:23404838]
17. Julia Niedźwiecka,Anna K Przybył,Maciej Kubicki.  (2013-02-21)  [Crystal and molecular structure of cytisine salts]..  Przeglad lekarski,  69  ((10)): (998-1003).  [PMID:23421078]
18. Iwona Zieleń,Mariola Sliwińska-Mossoń,Halina Milnerowicz.  (2013-02-21)  [Drugs used to treat nicotine addiction]..  Przeglad lekarski,  69  ((10)): (1098-1102).  [PMID:23421099]
19. Matthew R Costello,Daisy D Reynaga,Celina Y Mojica,Nurulain T Zaveri,James D Belluzzi,Frances M Leslie.  (2014-02-12)  Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats..  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,  39  ((8)): (1843-1851).  [PMID:24513971]
20. Jesse S Rodriguez,Colin S Cunningham,Fernando B Moura,Pauline Ondachi,F Ivy Carroll,Lance R McMahon.  (2014-05-08)  Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice..  Psychopharmacology,  231  ((23)): (4455-4466).  [PMID:24800895]
21. Kathryn M Albers,Xiu Lin Zhang,Charlotte M Diges,Erica S Schwartz,Charles I Yang,Brian M Davis,Michael S Gold.  (2014-06-03)  Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons..  Molecular pain,  10  (31-31).  [PMID:24886596]
22. Soo Hee Jeong,David Newcombe,Janie Sheridan,Malcolm Tingle.  (2014-09-19)  Pharmacokinetics of cytisine, an α4 β2 nicotinic receptor partial agonist, in healthy smokers following a single dose..  Drug testing and analysis,  7  ((6)): (475-482).  [PMID:25231024]
23. Yann S Mineur,Emily B Einstein,Matthew P Bentham,Mattis B Wigestrand,Sam Blakeman,Sylvia A Newbold,Marina R Picciotto.  (2014-10-08)  Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine..  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,  40  ((4)): (938-946).  [PMID:25288485]
24. Hong Xu,Jeffery A Boychuk,Carie R Boychuk,Victor V Uteshev,Bret N Smith.  (2014-11-28)  Nicotine enhances inhibition of mouse vagal motor neurons by modulating excitability of premotor GABAergic neurons in the nucleus tractus solitarii..  Journal of neurophysiology,  113  ((4)): (1165-1174).  [PMID:25429117]
25. Natalie Walker,Colin Howe,Marewa Glover,Hayden McRobbie,Joanne Barnes,Vili Nosa,Varsha Parag,Bruce Bassett,Christopher Bullen.  (2014-12-18)  Cytisine versus nicotine for smoking cessation..  The New England journal of medicine,  371  ((25)): (2353-2362).  [PMID:25517706]
26. Nancy A Rigotti.  (2014-12-18)  Cytisine--a tobacco treatment hiding in plain sight..  The New England journal of medicine,  371  ((25)): (2429-2430).  [PMID:25517710]
27. Erin E Meyers,Esteban C Loetz,Michael J Marks.  (2015-01-07)  Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment..  Pharmacology, biochemistry, and behavior,  130  (1-8).  [PMID:25560939]
28. Jean-François Etter.  (2006-08-16)  Cytisine for smoking cessation: a literature review and a meta-analysis..  Archives of internal medicine,  166  ((15)): (1553-1559).  [PMID:16908787]
29. Yann S Mineur,Oli Somenzi,Marina R Picciotto.  (2007-02-27)  Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice..  Neuropharmacology,  52  ((5)): (1256-1262).  [PMID:17320916]
30. Jean-François Etter,Ronald J Lukas,Neal L Benowitz,Robert West,Carolyn M Dresler.  (2007-09-11)  Cytisine for smoking cessation: a research agenda..  Drug and alcohol dependence,  92  ((1-3)): (3-8).  [PMID:17825502]
31. Christoph Hirschhäuser,Claire A Haseler,Timothy Gallagher.  (2011-04-27)  Core modification of cytisine: a modular synthesis..  Angewandte Chemie (International ed. in English),  50  ((22)): (5162-5165).  [PMID:21520366]
32. Hugo R Arias,Dominik Feuerbach,Katarzyna M Targowska-Duda,Krzysztof Jozwiak.  (2011-06-07)  Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states..  The international journal of biochemistry & cell biology,  43  ((9)): (1330-1339).  [PMID:21642011]
33. Yann S Mineur,Alfonso Abizaid,Yan Rao,Ramiro Salas,Ralph J DiLeone,Daniela Gündisch,Sabrina Diano,Mariella De Biasi,Tamas L Horvath,Xiao-Bing Gao,Marina R Picciotto.  (2011-06-11)  Nicotine decreases food intake through activation of POMC neurons..  Science (New York, N.Y.),  332  ((6035)): (1330-1332).  [PMID:21659607]
34. Magdalena Majewska,Jarosław Szponar,Elzbieta Pyra,Halina Kostek,Anna Kujawa.  (2011-10-21)  [Serotonin syndrome in the course of drug-poisoning--case presentation]..  Przeglad lekarski,  68  ((8)): (523-526).  [PMID:22010456]
35. P A Iavich,L I Churadze,T Sh Suladze,T A Rukhadze.  (2012-02-07)  [Development of quantitative analyse method for determination of alkaloid cytisin in Spartium junceum L., growing in Georgia]..  Georgian medical news,  (201)  ((201)): (65-69).  [PMID:22306505]
36. D S Turcanu,N Kirtok,C Eibl,D Guendisch,E F LaGamma,B B Nankova.  (2012-04-17)  Nicotinic receptor partial agonists alter catecholamine homeostasis and response to nicotine in PC12 cells..  Neuroscience letters,  516  ((2)): (212-216).  [PMID:22503726]
37. Noah S Philip,Linda L Carpenter,Audrey R Tyrka,Lawrence H Price.  (2012-05-24)  The nicotinic acetylcholine receptor as a target for antidepressant drug development..  TheScientificWorldJournal,  2012  (104105-104105).  [PMID:22619570]
38. Christopher I Richards,Khai Luong,Rahul Srinivasan,Stephen W Turner,Dennis A Dougherty,Jonas Korlach,Henry A Lester.  (2012-06-07)  Live-cell imaging of single receptor composition using zero-mode waveguide nanostructures..  Nano letters,  12  ((7)): (3690-3694).  [PMID:22668081]
39. Ravi K Sajja,Shafiqur Rahman.  (2012-06-29)  Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL/6J mice..  Pharmacology, biochemistry, and behavior,  102  ((1)): (36-43).  [PMID:22741175]
40. Paulo César Ghedini,Maria Christina W Avellar,Thereza Christina M De Lima,Maria Teresa R Lima-Landman,Antônio José Lapa,Caden Souccar.  (2012-09-22)  Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice..  Brain research,  1483  (96-104).  [PMID:22995368]
41. Hugo R Arias,Nikolai B Fedorov,Lisa C Benson,Patrick M Lippiello,Greg J Gatto,Dominik Feuerbach,Marcelo O Ortells.  (2012-09-27)  Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor..  The Journal of pharmacology and experimental therapeutics,  344  ((1)): (113-123).  [PMID:23010362]
42. Kasper Harpsøe,Helle Hald,Daniel B Timmermann,Marianne L Jensen,Tino Dyhring,Elsebet Ø Nielsen,Dan Peters,Thomas Balle,Michael Gajhede,Jette S Kastrup,Philip K Ahring.  (2012-12-12)  Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors..  The Journal of biological chemistry,  288  ((4)): (2559-2570).  [PMID:23229547]
43. Paul Aveyard,Robert West.  (2013-08-03)  Cytisine and the failure to market and regulate for human health..  Thorax,  68  ((11)): (989-989).  [PMID:23908130]
44. Can Peng,Clare Stokes,Yann S Mineur,Marina R Picciotto,Chengju Tian,Christoph Eibl,Isabelle Tomassoli,Daniela Guendisch,Roger L Papke.  (2013-08-21)  Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule..  The Journal of pharmacology and experimental therapeutics,  347  ((2)): (424-437).  [PMID:23959137]
45. Michael J Marks,Sharon R Grady,Outi Salminen,Miranda A Paley,Charles R Wageman,J Michael McIntosh,Paul Whiteaker.  (2014-03-26)  α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration..  Journal of neurochemistry,  130  ((2)): (185-198).  [PMID:24661093]
46. Edmund F LaGamma,Necla Kirtok,Owen Chan,Bistra B Nankova.  (2014-08-15)  Partial blockade of nicotinic acetylcholine receptors improves the counterregulatory response to hypoglycemia in recurrently hypoglycemic rats..  American journal of physiology. Endocrinology and metabolism,  307  ((7)): (E580-E588).  [PMID:25117409]
47. Zhang Chunhua, Wu Huiqin, Huang Xiaolan, Zhu Zhixin, Luo Huitai, Huang Fang, Lin Xiaoshan.  (2012)  Simultaneous Determination of Toxic Alkaloids in Blood and Urine by HPLC–ESI–MS/MS.  CHROMATOGRAPHIA,  75  (9): (499-511).  [PMID:] [10.1007/s10337-012-2216-6]

Solution Calculators

Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.